A novel method for simple detection of mutations conferring drug resistance in Mycobacterium leprae, based on a DNA microarray, and its applicability in developing countries
A simple method to detect mutations in the genome of Mycobacterium leprae that confer resistance to key drugs for leprosy was exploited on the basis of a reverse hybridization system. A series of oligonucleotide probes corresponding to each mutation in the folP1, rpoB and gyrA genes for dapsone, rifampicin and ofloxacin resistance, respectively, were selected and fixed on a glass slide as capture probes, to develop a DNA microarray termed the leprosy drug susceptibility-DNA microarray (LDS-DA). Mutations in clinical isolates of M. leprae were successfully identified by the LDS-DA. Feasibility studies were conducted to evaluate the performance of the LDS-DA in two developing countries, Myanmar and the Philippines. The high concordance of the results obtained by this method with the results of nucleotide sequencing strongly supports the applicability of the LDS-DA as a drug susceptibility test in place of sequencing, a time-consuming and costly procedure. This is a rapid and simple method for the simultaneous susceptibility testing of three front-line drugs for leprosy, and solves the problems of previously reported methods.
CambauE.,
BonnafousP.,
PeraniE.,
SougakoffW.,
JiB.,
JarlierV.2001; Molecular detection of rifampicin and ofloxacin resistance for patients who experience relapse of multibacillary leprosy. Clin Infect Dis 34:39–45
de WitM. Y. L.,
FaberW. R. S.,
KriegR.,
DouglasJ. T.,
LucasS. B.,
MontreewasuwatN.,
PattynS. R. N.,
HussainR.,
PonnighausJ. M.other authors1991; Application of polymerase chain reaction for the detection of Mycobacterium leprae in skin tissue. J Clin Microbiol 29:906–910
HonoréN.,
PeraniE.,
TelentiA.,
GrossetJ.,
ColeS. T.1993; A simple and rapid technique for the detection of rifampicin resistance in Mycobacterium leprae
. Int J Lepr Other Mycobact Dis 61:600–604
KaiM.,
MatsuokaM.,
NakataN.,
MaedaS.,
GidohM.,
MaedaY.,
HashimotoK.,
KobayashiK.,
KashiwabaraY.1999; Diaminodiphenilsulfone resistance of Mycobacterium leprae due to mutations in the dihydropteroate synthase gene. FEMS Microbiol Lett 177:231–235[CrossRef]
LeeS. B.,
KimS. K.,
KangT. J.,
ChaeG. T.,
ChunJ. H.,
ShinH. K.,
KimJ. P.,
KoY. H.,
KimN. H.2001; The prevalence of folP1 mutations associated with clinical resistance to dapsone, in Mycoabcterium leprae isolates from South Korea. Ann Trop Med Parasitol 95:429–432[CrossRef]
MatsuokaM.,
KashiwabaraY.,
NamisatoY.2000; A Mycobacterium leprae isolate resistant to dapsone, rifampicin, ofloxacine and sparfloxacin. Int J Lepr Other Mycobact Dis 68:452–455
MatsuokaM.,
KashiwabaraY.,
ZhangL.,
GotohM.,
KitajimaS.2003; A second case of multidrug resistant Mycobacterium leprae isolated from a Japanese patient with relapsed lepromatous leprosy. Int J Lepr Other Mycobact Dis 71:240–243[CrossRef]
MatsuokaM.,
ZhangL.,
MorrisM. F.,
LeguaP.,
WiensC.2005; Polymorphism in the rpoT gene in Mycobacterium leprae isolates obtained from Latin American countries and its possible correlation with the spread of leprosy. FEMS Microbiol Lett 243:311–315[CrossRef]
MatsuokaM.,
TekyB.,
KhinS. A.,
KyawK.,
TanE. V.,
dela CruzE.,
GelberR.,
SaundersonP.,
BalagonM. A.,
PannikarV.2007; The frequency of drug resistance mutations in Mycobacterium leprae isolates in untreated and relapsed leprosy patients from Myanmar, Indonesia and the Philippines. Lepr Rev 78:343–352
RossauR.,
TraoreH.,
de BeenhouwerH.,
MijsW.,
JannesG.,
De RijkP.,
PortaelsF.1997; Evaluation of the INNO-LiPA Rif. TB assay, a reverse hybridization assay for the simultaneous detection of Mycobacterium tuberculosis complex and its resistance to rifampicin. Antimicrob Agents Chemother 41:2093–2098
SapkotaB. R.,
RanjitC.,
NeupaneK. D.,
MacdonaldM.2008; Developing and evaluation of a novel multiple-primer PCR amplification refractory mutation system for the rapid detection of mutations conferring rifampicin resistance in codon 425 of the rpoB gene of Mycobacterium leprae
. J Med Microbiol 57:179–184[CrossRef]
WilliamsD. L.,
PittmanT. L.,
GillisT. P.,
MatsuokaM.,
KashiwabaraY.2001; Simultaneous detection of Mycobacterium leprae and its susceptibility to dapsone using DNA heteroduplex analysis. J Clin Microbiol 39:2083–2088[CrossRef]
ZhangL.,
NamisatoM.,
MatsuokaM.2004; A mutation at codon 516 in the rpoB gene of Mycobacterium leprae confers resistance to rifampicin. Int J Lepr Other Mycobact Dis 72:468–472[CrossRef]
A novel method for simple detection of mutations conferring drug resistance in Mycobacterium leprae, based on a DNA microarray, and its applicability in developing countries